The South San Francisco biotech announced that eIF2B agonist DNL343 was unable to slow disease progression or increase survival compared to placebo at 24 weeks in the study, conducted at Sean M ...

and UCB's complement C5 inhibitor zilucoplan – join Denali Therapeutics' DNL343 and AbbVie/Calico's fosigotifator, both eIF2B agonists, in failing to slow disease progression in the study.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

CBS News President and CEO Wendy McMahon announced Monday she was stepping down in another stunning move for the embattled company, Fox News Digital has confirmed. Her exit follows that of ...

Government Says It’s Halting Harvard’s Ability to Enroll International Students The move was a major escalation in the Trump administration’s efforts to pressure the college to fall in line ...

Filled with the top stories to start your day, and emergency news alerts.

A new walking tour celebrating a quirky detective show has had interest "from all over the country", its organiser says. John Hughes, who has run the "Haunted and Hidden Bristol" tour for more ...

The tenure of Maryland’s former Chief Medical Examiner Dr. David Fowler has been under review since his controversial testimony in the case of police officer Derek Chauvin who was convicted of ...

Tidball’s, Bowling Green’s renowned live music venue which served as a home stage for countless local bands that ... BY DAVID MAMARIL HOROWITZ [email protected] The Friday night ...

The appeal comes after President Donald Trump’s recent visit to the Gulf, during which he announced plans for American companies to supply tens of thousands of high-end AI chips to the region ...

A "share and repair" project has been awarded £11,000 to help encourage more people to reduce, reuse and recycle. The funding, provided by the Somerset Community Foundation, will go towards a ...